CA2416963A1 - Methods and compositions for amplification of rna sequences - Google Patents
Methods and compositions for amplification of rna sequences Download PDFInfo
- Publication number
- CA2416963A1 CA2416963A1 CA002416963A CA2416963A CA2416963A1 CA 2416963 A1 CA2416963 A1 CA 2416963A1 CA 002416963 A CA002416963 A CA 002416963A CA 2416963 A CA2416963 A CA 2416963A CA 2416963 A1 CA2416963 A1 CA 2416963A1
- Authority
- CA
- Canada
- Prior art keywords
- rna
- primer
- dna
- extension product
- composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
Abstract
The invention provides methods for isothermal amplification of RNA. The methods are particularly suitable for amplifying a plurality of RNA species in a sample. The methods employ a composite primer, a second primer and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In another aspect, the methods employ a single primer (which is a composite primer) and strand displacement to generate multiple copies of DNA products comprising sequences complementary to an RNA sequence of interest. In some embodiments, a transcription step is included to generate multiple copies of sense RNA of an RNA sequence of interest. The methods are useful for preparation of nucleic acid libraries and substrates for analysis of gene expression of cells in biological samples. The invention also provides compositions and kits for practicing the amplification methods, as well as methods which use the amplification products.
Claims (161)
1. A method of generating multiple copies of a polynucleotide sequence complementary to an RNA sequence of interest, said method comprising the steps of:
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(e) extending the composite primer hybridized to the second primer extension product with a DNA-dependent DNA polymerase;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(e) extending the composite primer hybridized to the second primer extension product with a DNA-dependent DNA polymerase;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
2. The method of claim 1, wherein the second primer comprises a fragment of the target RNA hybridized to the primer extension product, said fragment generated by~
cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA from an RNA/DNA hybrid.
cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA from an RNA/DNA hybrid.
3. The method of claim 1, wherein the second primer comprises DNA.
4. The method of claim 1, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion.
5. The method of claim 4, wherein the 5' RNA portion is adjacent to the 3' DNA portion.
6. The method of claim 1, wherein the composite primer that hybridizes to target RNA comprises a 5' portion that is not hybridizable to the target RNA
under conditions which the composite primer hybridizes to the target RNA.
under conditions which the composite primer hybridizes to the target RNA.
7. The method of claim 1, wherein the composite primer that hybridizes to target RNA comprises a poly-dT sequence.
8. The method of claim 7, wherein the target RNA is mRNA.
9. The method of claim 1, wherein the composite primer that hybridizes to target RNA comprises a random sequence.
10. The method of claim 1, wherein the target RNA is mRNA, and the composite primer that hybridizes to target RNA comprises a poly-dT sequence, and further comprises a 5' portion that is not hybridizable to the target mRNA under conditions which the composite primer hybridizes to the target mRNA.
11. The method of claim 1, wherein a plurality of different composite primers are used for hybridizing to the target RNA.
12. The method of claim 1, wherein the second primer is a random primer.
13. The method of claim 1, wherein the second primer comprises a 5' portion that is not hybridizable to the first primer extension product under conditions which the second primer hybridizes to the first primer extension product.
14. The method of claim 1, wherein the enzyme that cleaves RNA from an RNA/DNA hybrid is RNase H.
15. The method of claim 1, wherein the RNA -dependent DNA polymerase and DNA-dependent DNA polymerase are the same enzyme.
16. The method of claim 1, wherein the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
17. The method of claim 1, wherein the DNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
18. The method of claim 1, wherein the DNA-dependent DNA polymerase, the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA
hybrid are the same enzyme.
hybrid are the same enzyme.
19. The method of claim 1, wherein at least one type of dNTP used is a labeled dNTP, whereby labeled products are generated.
20. The method of claim 1, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are the same.
21. The method of claim 1, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are different.
22. The method of claim 1, wherein said method comprises generating multiple copies of a polynucleotide sequence complementary to two or more different sequences of interest.
23. The method of claim 22, wherein said method comprises at least two different composite primers that hybridize to target RNA.
24. The method of claim 22 or 23, wherein the composite primer that hybridizes to target RNA comprises a poly-dT portion.
25. The method of claim 22 or 23, wherein the composite primer that hybridizes to target RNA is a random primer.
26. A method of generating multiple copies of an RNA sequence of interest, said method comprising the steps of:
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(e) extending said composite primer hybridized to the second primer extension product with a DNA-dependent DNA polymerase, whereby said first primer extension product is displaced;
(f) hybridizing the displaced first primer extension product with a polynucleotide comprising a propromoter and a region which is hybridizable to the displaced first primer extension product under conditions which allow transcription to occur by RNA polymerase, such that RNA transcripts are produced comprising sequences complementary to the displaced first primer extension product, whereby multiple copies of the RNA sequence of interest are generated.
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(e) extending said composite primer hybridized to the second primer extension product with a DNA-dependent DNA polymerase, whereby said first primer extension product is displaced;
(f) hybridizing the displaced first primer extension product with a polynucleotide comprising a propromoter and a region which is hybridizable to the displaced first primer extension product under conditions which allow transcription to occur by RNA polymerase, such that RNA transcripts are produced comprising sequences complementary to the displaced first primer extension product, whereby multiple copies of the RNA sequence of interest are generated.
27. The method of claim 26, wherein the second primer comprises a fragment of the target RNA hybridized to the primer extension product, said fragment generated by cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA from an RNA/DNA hybrid.
28. The method of claim 26, wherein the second primer comprises DNA.
29. The method of claim 26, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion.
30. The method of claim 29, wherein the 5' RNA portion is adjacent to the 3' DNA portion.
31. The method of claim 26, wherein the composite primer that hybridizes to target RNA comprises a 5' portion that is not hybridizable to the target RNA
under conditions which the composite primer hybridizes to the target RNA.
under conditions which the composite primer hybridizes to the target RNA.
32. The method of claim 26, wherein the composite primer that hybridizes to target RNA comprises a poly-dT sequence.
33. The method of claim 26, wherein the target RNA is mRNA.
gccttcgacg aagccggtcc ggacgcagcg
gccttcgacg aagccggtcc ggacgcagcg
34. The method of claim 26, wherein the composite primer that hybridizes to target RNA comprises a random sequence.
35. The method of claim 26, wherein the target RNA is mRNA, and the composite primer that hybridizes to target RNA comprises a poly-dT sequence, and further comprises a 5' portion that is not hybridizable to the target mRNA under conditions which the composite primer hybridizes to the target mRNA.
36. The method of claim 26, wherein a plurality of different composite primers are used for hybridizing to the target RNA.
37. The method of claim 26, wherein the second primer is a random primer.
38. The method of claim 26, wherein the second primer comprises a 5' portion that is not hybridizable to the first primer extension product under conditions which the second primer hybridizes to the fist primer extension product.
39. The method of claim 26, wherein the enzyme that cleaves RNA from an RNA/DNA hybrid is RNase H.
40. The method of claim 26, wherein the RNA-dependent DNA polymerase and DNA-dependent DNA polymerase are the same enzyme.
41. The method of claim 26, wherein the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
42. The method of claim 26, wherein the DNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
43. The method of claim 26, wherein the DNA-dependent DNA polymerase, the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA
hybrid are the same enzyme.
hybrid are the same enzyme.
44. The method of claim 26, wherein at least one type of dNTP used is a labeled dNTP, whereby labeled products are generated.
45. The method of claim 26, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are the same.
46. The method of claim 26, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are different.
47. The method of claim 26, wherein the propromoter polynucleotide comprises a region at the 3' end which hybridizes to the displaced primer extension product, whereby DNA polymerase extension of displaced primer extension product produces a double stranded promoter from which transcription occurs.
48. The method of claim 26, wherein the propromoter polynucleotide is a propromoter template oligonucleotide (PTO).
49. The method of claim 26, wherein at least one type of rNTP used is a labeled rNTP, whereby labeled products are generated.
50. The method of claim 26, wherein said method comprises generating multiple copies of two or more different sequences of interest.
51. The method of claim 50, wherein said method comprises at least two different composite primers that hybridize to target RNA.
52. The method of claim 50 or 51, wherein the composite primer that hybridizes to target RNA comprises a poly-dT portion.
53. The method of claim 50 or 51, wherein the composite primer that hybridizes to target RNA is a random primer.
54. A method of amplifying an RNA sequence of interest, comprising incubating a reaction mixture, said reaction mixture comprising:
(a) the complex of first and second primer extension products of step (c) of claim 1;
(b) a composite primer that is hybridizable to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(c) a DNA-dependent DNA polymerase; and (d) an enzyme that cleaves RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, RNA
cleavage, and displacement of the first primer extension product from the complex of step (c) of claim 1 when its RNA is cleaved and a composite primer binds to the second primer extension product in the complex and is extended, whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
(a) the complex of first and second primer extension products of step (c) of claim 1;
(b) a composite primer that is hybridizable to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(c) a DNA-dependent DNA polymerase; and (d) an enzyme that cleaves RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, RNA
cleavage, and displacement of the first primer extension product from the complex of step (c) of claim 1 when its RNA is cleaved and a composite primer binds to the second primer extension product in the complex and is extended, whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
55. The method of claim 54, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion, and the 5' RNA
portion is adjacent to the 3' DNA portion.
portion is adjacent to the 3' DNA portion.
56. The method of claim 54, wherein the target RNA is mRNA.
57. The method of claim 54, wherein at least one type of dNTP used is a labeled dNTP, wherein labeled products are generated.
58. A method of amplifying an RNA sequence of interest comprising incubating a reaction mixture, said reaction mixture comprising:
(a) a first complex, wherein the first complex is the complex of first and second primer extension products of step (c) of claim 1;
(b) a composite primer that is hybridizable to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(c) a DNA-dependent DNA polymerase;
(d) an RNA polymerase;
(e) a propromoter polynucleotide comprising a propromoter and a region which hybridizes to a second primer extension product; and (f) an enzyme that cleaves RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, RNA
cleavage, displacement of the first primer extension product from the first complex when its RNA is cleaved and a composite primer binds to the second primer extension product in the first complex, hybridization of the propromoter polynucleotide to the displaced first primer extension product to form a second complex comprising the displaced primer extension product and the propromoter polynucleotide, and RNA transcription from said second complex, whereby multiple copies of the RNA sequence of interest are generated.
(a) a first complex, wherein the first complex is the complex of first and second primer extension products of step (c) of claim 1;
(b) a composite primer that is hybridizable to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion;
(c) a DNA-dependent DNA polymerase;
(d) an RNA polymerase;
(e) a propromoter polynucleotide comprising a propromoter and a region which hybridizes to a second primer extension product; and (f) an enzyme that cleaves RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, RNA
cleavage, displacement of the first primer extension product from the first complex when its RNA is cleaved and a composite primer binds to the second primer extension product in the first complex, hybridization of the propromoter polynucleotide to the displaced first primer extension product to form a second complex comprising the displaced primer extension product and the propromoter polynucleotide, and RNA transcription from said second complex, whereby multiple copies of the RNA sequence of interest are generated.
59. The method of claim 58, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion, and the 5' RNA
portion is adjacent to the 3' DNA portion.
portion is adjacent to the 3' DNA portion.
60. The method of claim 58, wherein the enzyme that cleaves RNA from an RNA/DNA hybrid is RNase H.
61. The method of claim 58, wherein the propromoter polynucleotide comprises a region at the 3' end which hybridizes to the displaced primer extension product, whereby DNA polymerase extension of displaced primer extension product produces a double stranded promoter from which transcription occurs.
62. The method of claim 58, wherein at least one type of rNTP used is a labeled rNTP, whereby labeled products are generated.
63. The method of claim 58, wherein the target RNA is mRNA.
64. A method of generating multiple copies of (amplifying) an RNA sequence of interest comprising:
(a) incubating a reaction mixture, said reaction mixture comprising:
(i) a target RNA;
(ii) a first primer that is hybridizable to a target RNA, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion;
(iii) a RNA-dependent DNA polymerase; and (iv) an enzyme capable of cleaving RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, formation of a complex comprising a first primer extension product and the target RNA
and cleavage of RNA in the complex comprising a first primer extension product and the target RNA;
(b) incubating a reaction mixture, said reaction mixture comprising:
(i) the first primer extension product;
(ii) a DNA-dependent DNA polymerase; and (iii) optionally, an enzyme capable of cleaving RNA from an RNA/DNA
hybrid;
wherein the incubation is under conditions permitting formation of a complex comprising the first primer extension product and a second primer extension product, and optionally, cleavage of RNA in the complex comprising a first primer extension product and the target RNA;
(c) incubating a reaction mixture, said reaction mixture comprising:
(i) the complex comprising the first primer extension product and a second primer extension product;
(ii) an enzyme capable of cleaving RNA from an RNA/DNA hybrid;
(iii) a composite primer, wherein the composite primer comprises a RNA
portion and a 3' DNA portion;
(iv) the cleaved complex comprising the first primer extension product and a second primer extension product; and (v) DNA-dependent DNA polymerase, wherein the incubation is under conditions that permit cleavage of RNA in the complex comprising the first primer extension product and a second primer extension product, composite primer hybridization, and displacement of the first primer extension product from the complex comprising the first primer extension product and a second primer extension product;
whereby multiple copies of a polynucleotide sequence complementary to the RNA
sequence of interest are generated.
(a) incubating a reaction mixture, said reaction mixture comprising:
(i) a target RNA;
(ii) a first primer that is hybridizable to a target RNA, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion;
(iii) a RNA-dependent DNA polymerase; and (iv) an enzyme capable of cleaving RNA from an RNA/DNA hybrid;
wherein the incubation is under conditions that permit primer hybridization, formation of a complex comprising a first primer extension product and the target RNA
and cleavage of RNA in the complex comprising a first primer extension product and the target RNA;
(b) incubating a reaction mixture, said reaction mixture comprising:
(i) the first primer extension product;
(ii) a DNA-dependent DNA polymerase; and (iii) optionally, an enzyme capable of cleaving RNA from an RNA/DNA
hybrid;
wherein the incubation is under conditions permitting formation of a complex comprising the first primer extension product and a second primer extension product, and optionally, cleavage of RNA in the complex comprising a first primer extension product and the target RNA;
(c) incubating a reaction mixture, said reaction mixture comprising:
(i) the complex comprising the first primer extension product and a second primer extension product;
(ii) an enzyme capable of cleaving RNA from an RNA/DNA hybrid;
(iii) a composite primer, wherein the composite primer comprises a RNA
portion and a 3' DNA portion;
(iv) the cleaved complex comprising the first primer extension product and a second primer extension product; and (v) DNA-dependent DNA polymerase, wherein the incubation is under conditions that permit cleavage of RNA in the complex comprising the first primer extension product and a second primer extension product, composite primer hybridization, and displacement of the first primer extension product from the complex comprising the first primer extension product and a second primer extension product;
whereby multiple copies of a polynucleotide sequence complementary to the RNA
sequence of interest are generated.
65. The method of claim 64, wherein step (b) includes incubating a reaction mixture further comprising: (iv) a second primer; and wherein the incubation is under conditions permitting hybridization of the second primer.
66. The method of claim 65, wherein the second primer comprises DNA.
67. The method of claim 64, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion.
68. The method of claim 67, wherein the 5' RNA portion is adjacent to the 3' DNA portion.
69. The method of claim 64, wherein the composite primer that hybridizes to target RNA comprises a 5' portion that is not hybridizable to the target RNA
under conditions which the composite primer hybridizes to the target RNA.
under conditions which the composite primer hybridizes to the target RNA.
70. The method of claim 64, wherein the composite primer that hybridizes to target RNA comprises a poly-dT sequence.
71. The method of claim 64, wherein the target RNA is mRNA.
72. The method of claim 64, wherein the composite primer that hybridizes to target RNA comprises a random sequence.
73. The method of claim 64, wherein the target RNA is mRNA, and the composite primer that hybridizes to target RNA comprises a poly-dT sequence, and further comprises a 5' portion that is not hybridizable to the target mRNA under conditions which the composite primer hybridizes to the target mRNA.
74. The method of claim 64, wherein a plurality of different composite primers are used for hybridizing to the target RNA.
75. The method of claim 64, wherein the second primer is a random primer.
76. The method of claim 64, wherein the second primer comprises a 5' portion that is not hybridizable to the first primer extension product under conditions which the second primer hybridizes to the first primer extension product.
77. The method of claim 64, wherein the enzyme that cleaves RNA from an RNA/DNA hybrid is RNase H.
78. The method of claim 64, wherein the RNA -dependent DNA polymerase and DNA-dependent DNA polymerase are the same enzyme.
79. The method of claim 64, wherein the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
80. The method of claim 64, wherein the DNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme.
81. The method of claim 64, wherein the DNA-dependent DNA polymerase, the RNA-dependent DNA polymerase and the enzyme that cleaves RNA from an RNA/DNA
hybrid are the same enzyme.
hybrid are the same enzyme.
82. The method of claim 64, wherein at least one type of dNTP used is a labeled dNTP, whereby labeled products are generated.
83. The method of claim 64, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are the same.
84. The method of claim 64, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are different.
85. The method of claim 64, wherein said method comprises generating multiple copies of a polynucleotide sequence complementary to two or more different sequences of interest.
86. The method of claim 85, wherein said method comprises at least two different composite primers that hybridize to target RNA.
87. The method of claim 85 or 86, wherein the composite primer that hybridizes to target RNA comprises a poly-dT portion.
88. The method of claim 85 or 86, wherein the composite primer that hybridizes to target RNA is a random primer.
89. A method of generating multiple copies of a polynucleotide sequence complementary to an RNA sequence of interest, said method comprising the steps of:
(a) cleaving RNA from a complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion, wherein the first primer extension product is produced by extension of a first primer hybridized to a target RNA
with a RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion;
(b) hybridizing a composite primer to the second primer extension product and extending the composite primer with a DNA-dependent DNA polymerase;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
(a) cleaving RNA from a complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA hybrid such that a composite primer hybridizes to the second primer extension product, wherein the composite primer comprises an RNA portion and a 3' DNA portion, wherein the first primer extension product is produced by extension of a first primer hybridized to a target RNA
with a RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion;
(b) hybridizing a composite primer to the second primer extension product and extending the composite primer with a DNA-dependent DNA polymerase;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
90. The method of claim 89, wherein the second primer comprises DNA.
91. The method of claim 89, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion.
92. The method of claim 91, wherein the 5' RNA portion is adjacent to the 3' DNA portion.
93. The method of claim 89, wherein the composite primer that hybridizes to target RNA comprises a 5' portion that is not hybridizable to the target RNA
under conditions which the composite primer hybridizes to the target RNA.
under conditions which the composite primer hybridizes to the target RNA.
94. The method of claim 89, wherein the composite primer that hybridizes to target RNA comprises a poly-dT sequence.
95. The method of claim 94, wherein the target RNA is mRNA.
96. A method of generating multiple copies of a polynucleotide sequence complementary to an RNA sequence of interest, said method comprising the step of:
extending a composite primer in a complex comprising:
(i) a complex of a first and second primer extension products, wherein the first primer extension product is produced by extension of a first primer hybridized to a target RNA with a RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion, wherein the second primer extension product is generated by extension of a second primer hybridized to the first primer extension product, and wherein RNA from the complex of first and second primer extension products is cleaved with an enzyme that cleaves RNA from an RNA/DNA hybrid; and (ii) a composite primer, said composite primer comprising an RNA portion and a 3' DNA portion, wherein the composite primer is hybridized to the second primer extension product, and wherein the composite primer may be the same or different from the first primer;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
extending a composite primer in a complex comprising:
(i) a complex of a first and second primer extension products, wherein the first primer extension product is produced by extension of a first primer hybridized to a target RNA with a RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA portion, wherein the second primer extension product is generated by extension of a second primer hybridized to the first primer extension product, and wherein RNA from the complex of first and second primer extension products is cleaved with an enzyme that cleaves RNA from an RNA/DNA hybrid; and (ii) a composite primer, said composite primer comprising an RNA portion and a 3' DNA portion, wherein the composite primer is hybridized to the second primer extension product, and wherein the composite primer may be the same or different from the first primer;
whereby said first primer extension product is displaced, and whereby multiple copies of a polynucleotide sequence complementary to the RNA sequence of interest are generated.
97. The method of claim 96, wherein the second primer comprises DNA.
98. The method of claim 96, wherein the RNA portion of the composite primer that hybridizes to target RNA is 5' with respect to the 3' DNA portion.
99. The method of claim 98, wherein the 5' RNA portion is adjacent to the 3' DNA portion.
100. The method of claim 96, wherein the composite primer that hybridizes to target RNA comprises a 5' portion that is not hybridizable to the target RNA
under conditions which the composite primer hybridizes to the target RNA.
under conditions which the composite primer hybridizes to the target RNA.
101. The method of claim 96, wherein the composite primer that hybridizes to target RNA comprises a poly-dT sequence.
102. The method of claim 101, wherein the target RNA is mRNA.
103. A method of sequencing an RNA sequence of interest, said method comprising (a) amplifying a target RNA containing the sequence of interest by any of the methods of claims 1, 54, 64, 89, and 96 in the presence of a mixture of dNTPs and dNTP
analogs such that primer extension is terminated upon incorporation of a dNTP
analog; and (b) analyzing the amplification products to determine sequence.
analogs such that primer extension is terminated upon incorporation of a dNTP
analog; and (b) analyzing the amplification products to determine sequence.
104. The method of claim 103, wherein the target RNA is mRNA.
105. A method of sequencing an RNA sequence of interest, said method comprising (a) amplifying a target RNA containing the sequence of interest by any of the methods of claims 26 and 58 in the presence of a mixture of rNTPs and rNTP
analogs such that transcription is terminated upon incorporation of a rNTP analog; and (b) analyzing the amplification products to determine sequence.
analogs such that transcription is terminated upon incorporation of a rNTP analog; and (b) analyzing the amplification products to determine sequence.
106. The method of claim 105, wherein the target RNA is mRNA.
107. A method of detecting a mutation in a target RNA by single stranded conformation polymorphism, comprising (a) amplifying the target RNA by any of the methods of claims 1, 26, 54, 58, 64, 89, and 96; and (b) analyzing the amplification products for single stranded conformation, wherein a difference in conformation as compared to a reference single stranded polynucleotide indicates a mutation in the target polynucleotide.
108. The method of claim 107, wherein the target RNA is mRNA.
109. A method of determining presence or absence of a sequence of interest, said method comprising (i) amplifying a target RNA containing the sequence of interest, said amplifying comprising extending a composite primer hybridized to the complex of step (d) of claim 1, wherein the sequence of the RNA portion of the composite primer is known, and (ii) comparing the amplification products if any from step (i) with the amount of amplification products from a reference template wherein (1) production of detestably fewer amplification products from the template as compared to the amount of amplification products from the reference template which comprises a region hybridizable to the RNA portion of the composite primer indicates that the second primer extension product does not comprise a sequence hybridizable to the RNA portion of the composite primer and is a sequence variant with respect to the sequence hybridizable to the RNA portion of the composite primer; or (2) production of detectably more amplification products from the template as compared to the amount of amplification products from the reference template which does not comprise a region which is hybridizable to the RNA portion of the composite primer indicates that the second primer extension product comprises a sequence hybridizable to the RNA portion of the composite primer and is not a sequence variant with respect to the sequence hybridizable to the RNA portion of the composite primer.
110. The method of claim 109, wherein the target RNA is mRNA.
111. A method of producing a nucleic acid immobilized to a substrate, comprising (a) amplifying a target RNA by any of the methods of claims 1, 26, 54, 58, 64, 89, and 96; and (b) immobilizing the amplification products on a substrate.
112. The method of claim 111, wherein the target RNA is mRNA.
113. The method of claim 111, wherein the substrate is a microarray.
114. A method of characterizing an RNA sequence of interest, comprising (a) amplifying a target RNA by any of the methods of claims 1, 54, 64, 89, and 96;
and (b) analyzing the DNA products.
and (b) analyzing the DNA products.
115. The method of claim 114, wherein the target RNA is mRNA.
116. The method of claim 114, wherein the DNA products are labeled.
117. The method of claim 114, wherein step (b) of analyzing the DNA products comprises determining amount of said products, whereby the amount of the RNA
sequence of interest present in a sample is quantified.
sequence of interest present in a sample is quantified.
118. The method of claim 114, wherein step (b) comprises contacting the DNA
products with at least one probe.
products with at least one probe.
119. The method of claim 118, wherein the DNA products are labeled, and wherein the at least one probe is provided as a microarray.
120. The method of claim 119, wherein the microarray comprises at least one probe immobilized on a substrate fabricated from a material selected from the group consisting of paper, glass, ceramic, plastic, polypropylene, polystyrene, nylon, polyacrylamide, nitrocellulose, silicon, and optical fiber.
121. The method of claim 120, wherein the probe is immobilized on the substrate in a two-dimensional configuration or a three-dimensional configuration comprising pins, rods, fibers, tapes, threads, beads, particles, microtiter wells, capillaries, and cylinders.
122. A method of characterizing an RNA sequence of interest, comprising (a) amplifying a target RNA by the methods of any of claims 26 and 58; and (b) analyzing the RNA products.
123. The method of claim 122, wherein the target RNA is mRNA.
124. The method of claim 122, wherein the RNA products are labeled.
125. The method of claim 122, wherein step (b) of analyzing the RNA products comprises determining amount of said products, whereby the amount of the RNA
sequence of interest present in a sample is quantified.
sequence of interest present in a sample is quantified.
126. The method of claim 122, wherein step (b) comprises contacting the labeled RNA products with at least one probe.
127. The method of claim 122, wherein the RNA products are labeled, and wherein the at least one probe is provided as a microarray.
128. The method of claim 127, wherein the microarray comprises at least one probe immobilized on a substrate fabricated from a material selected from the group consisting of paper, glass, ceramic, plastic, polypropylene, polystyrene, nylon, polyacrylamide, nitrocellulose, silicon, and optical fiber.
129. The method of claim 128, wherein the probe is immobilized on the substrate in a two-dimensional configuration or a three-dimensional configuration comprising pins, rods, fibers, tapes, threads, beads, particles, microtiter wells, capillaries, and cylinders.
130. A method of determining gene expression profile in a sample, said method comprising: (a) amplifying at least one RNA sequence of interest in the sample using the method of any of claims 1, 54, 64, 89, and 96; and (b) determining amount of amplification products of each RNA sequence of interest, wherein each said amount is indicative of amount of each RNA sequence of interest in the sample, whereby the gene expression profile in the sample is determined.
131. The method of claim 130, wherein each target RNA is mRNA.
132. A method of preparing a library, said method comprising: amplifying at least one RNA sequences of interest using the method of any of claims 1, 26, 54, 58, 64, 89, and 96.
133. The method of claim 132, wherein the first primer that hybridizes to target RNA is a random primer
134. The method of claim 132, wherein the first primer that hybridizes to target RNA comprises a poly-dT portion.
135. A method of preparing a subtractive hybridization probe, said method comprising generating multiple DNA copies of the complement of at least one RNA
sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96.
sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96.
136. A method of performing subtractive hybridization, said method comprising:
(a) generating multiple DNA copies of the complement of at least one RNA
sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96; and (b) hybridizing the multiple copies to a second mRNA population, whereby a subpopulation of the second mRNA population forms a complex with a DNA copy.
(a) generating multiple DNA copies of the complement of at least one RNA
sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96; and (b) hybridizing the multiple copies to a second mRNA population, whereby a subpopulation of the second mRNA population forms a complex with a DNA copy.
137. The method of claim 136, said method further comprising: (c) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA from an RNA/DNA
hybrid; and (d) amplifying an unhybridized subpopulation of the second mRNA
population, whereby multiple copies of single stranded DNA complementary to the unhybridized subpopulation of the second mRNA population are generated.
hybrid; and (d) amplifying an unhybridized subpopulation of the second mRNA
population, whereby multiple copies of single stranded DNA complementary to the unhybridized subpopulation of the second mRNA population are generated.
138. A method for differential amplification of one or more RNA sequence of interest, said method comprising:
(a) hybridizing multiple polynucleotide copies of the complement of one or more RNA sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96 to a second mRNA population, whereby a subpopulation of the second mRNA population hybridizes to the polynucleotide copies to form complexes;
(b) cleaving RNA in the complexes of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid; and (c) amplifying an unhybridized subpopulation of the second mRNA population, whereby multiple copies of single stranded DNA complementary to the unhybridized subpopulation of the second mRNA population are generated.
(a) hybridizing multiple polynucleotide copies of the complement of one or more RNA sequence of interest from a first RNA population using the methods of any of claims 1, 54, 64, 89, and 96 to a second mRNA population, whereby a subpopulation of the second mRNA population hybridizes to the polynucleotide copies to form complexes;
(b) cleaving RNA in the complexes of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid; and (c) amplifying an unhybridized subpopulation of the second mRNA population, whereby multiple copies of single stranded DNA complementary to the unhybridized subpopulation of the second mRNA population are generated.
139. A method for making a cDNA library, said method comprising: preparing a subtractive hybridization probe according to claim 84.
140. A composition comprising a composite primer, wherein the composite primer comprises an RNA portion and a 3' DNA portion, and a second primer.
141. The composition of claim 140, wherein the second primer comprises DNA.
142. The composition of claim 141, wherein the second primer is a random primer.
143. The composition of claim 140, wherein the second primer comprises a fragment of the target RNA hybridized to the primer extension product.
144. The composition of claim 140, further comprising an RNA-dependent DNA
polymerase.
polymerase.
145. The composition of claim 140, wherein the composite primer further comprises a 5' region that is not hybridizable to the RNA sequence of interest under conditions which the composite primer hybridizes to the target RNA.
146. A composition comprising a composite primer and a second primer that comprises a sequence that is not hybridizable to a first primer extension product under conditions which the composite primer hybridizes to the target RNA.
147. A composition comprising: (a) a composite primer; (b) a second primer;
and (c) a propromoter polynucleotide.
and (c) a propromoter polynucleotide.
148. The composition of claim 147, wherein the second primer is a random primer.
149. A composition comprising a complex of (a) a first primer extension product, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA
portion; and (b) a propromoter polynucleotide.
portion; and (b) a propromoter polynucleotide.
150. A composition comprising a complex of (a) a first primer extension product, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA
portion; and (b) a second primer extension product, wherein the second primer comprises DNA.
portion; and (b) a second primer extension product, wherein the second primer comprises DNA.
151. A composition comprising a complex of (a) a first primer extension product, wherein the first primer is a composite primer comprising an RNA portion and a 3' DNA
portion; and (b) a second primer extension product, wherein the second primer comprises a fragment of the RNA target.
portion; and (b) a second primer extension product, wherein the second primer comprises a fragment of the RNA target.
152. A composition comprising a complex of (a) a cleaved primer extension product, wherein the primer is a composite primer comprising an RNA portion and a 3' DNA portion; (b) a second primer extension product; and (c) a composite primer that hybridizes to second primer extension product.
153. The method of claim 152, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are the same.
154. The method of claim 152, wherein the composite primer that hybridizes to target RNA and the composite primer that hybridizes to second primer extension product are different.
155. A reaction mixture comprising (a) a target RNA; (b) a composite primer comprising a 3' DNA portion and an RNA portion; (c) a second primer; and (d) a DNA
polymerase.
polymerase.
156. The reaction mixture of claim 155, further comprising: (e) an enzyme which cleaves RNA from an RNA/DNA hybrid.
157. The reaction mixture of claim 155, further comprising: (e) a propromoter polynucleotide.
158. A kit for amplifying a target RNA, comprising: (a) a composite primer comprising a 3' DNA portion and an RNA portion; (b) a second primer; and (c) instructions for amplifying RNA according to any of methods 1, 26, 54, 58, 64, 89, and 96.
159. The kit of claim 158, further comprising: (d) a propromoter polynucleotide.
160. The kit of claim 157 or 158, further comprising an enzyme which cleaves RNA from an RNA/DNA hybrid.
161. A method of making a complex of first and second primer extension products comprising a 3' single stranded portion comprising:
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid;
whereby a complex of first and second primer extension products comprising a 3' single stranded portion is generated;
whereby the 3' single stranded portion is complementary to the RNA portion of the composite primer.
(a) extending a first primer hybridized to a target RNA with an RNA-dependent DNA polymerase, wherein the first primer is a composite primer comprising an RNA
portion and a 3' DNA portion, whereby a complex comprising a first primer extension product and the target RNA is produced;
(b) cleaving RNA in the complex of step (b) with an enzyme that cleaves RNA
from an RNA/DNA hybrid;
(c) extending a second primer hybridized to the first primer extension product with a DNA-dependent DNA polymerase, whereby a second primer extension product is produced to form a complex of first and second primer extension products;
(d) cleaving RNA from the composite primer in the complex of first and second primer extension products with an enzyme that cleaves RNA from an RNA/DNA
hybrid;
whereby a complex of first and second primer extension products comprising a 3' single stranded portion is generated;
whereby the 3' single stranded portion is complementary to the RNA portion of the composite primer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27455001P | 2001-03-09 | 2001-03-09 | |
US60/274,550 | 2001-03-09 | ||
PCT/US2002/007306 WO2002072772A2 (en) | 2001-03-09 | 2002-03-11 | Methods and compositions for amplification of rna sequences |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2416963A1 true CA2416963A1 (en) | 2002-09-19 |
CA2416963C CA2416963C (en) | 2012-01-10 |
Family
ID=23048664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2416963A Expired - Fee Related CA2416963C (en) | 2001-03-09 | 2002-03-11 | Methods and compositions for amplification of rna sequences |
Country Status (17)
Country | Link |
---|---|
US (7) | US6946251B2 (en) |
EP (1) | EP1366197B1 (en) |
JP (3) | JP4542312B2 (en) |
KR (1) | KR20030082535A (en) |
CN (1) | CN1289690C (en) |
AT (1) | ATE361996T1 (en) |
AU (1) | AU2002252279B2 (en) |
BR (1) | BR0205268A (en) |
CA (1) | CA2416963C (en) |
DE (1) | DE60220025T2 (en) |
HK (1) | HK1059097A1 (en) |
IL (1) | IL153504A0 (en) |
MX (1) | MXPA02012739A (en) |
NO (1) | NO20030557D0 (en) |
NZ (1) | NZ523167A (en) |
WO (1) | WO2002072772A2 (en) |
ZA (1) | ZA200210369B (en) |
Families Citing this family (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692918B2 (en) * | 1999-09-13 | 2004-02-17 | Nugen Technologies, Inc. | Methods and compositions for linear isothermal amplification of polynucleotide sequences |
US7846733B2 (en) | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
WO2002000938A2 (en) * | 2000-06-26 | 2002-01-03 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
WO2002048402A2 (en) | 2000-12-13 | 2002-06-20 | Nugen Technologies, Inc. | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
US7094536B2 (en) * | 2001-03-09 | 2006-08-22 | Nugen Technologies, Inc. | Methods and compositions for amplification of RNA sequences |
ZA200210369B (en) | 2001-03-09 | 2004-07-08 | Nugen Technologies Inc | Methods and compositions for amplification or RNA sequences. |
CA2444649C (en) | 2001-04-20 | 2012-10-02 | The Penn State Research Foundation | Methods for nucleic acid manipulation |
US7176025B2 (en) | 2002-03-11 | 2007-02-13 | Nugen Technologies, Inc. | Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination |
US20040023271A1 (en) * | 2002-03-29 | 2004-02-05 | Nurith Kurn | Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
US20040005614A1 (en) * | 2002-05-17 | 2004-01-08 | Nurith Kurn | Methods for fragmentation, labeling and immobilization of nucleic acids |
ATE411400T1 (en) | 2002-11-21 | 2008-10-15 | Epict Technologies | METHOD FOR USING RIBOPRIMERS FOR STRAND DISPLACEMENT REPLICATION OF TARGET SEQUENCES |
US8206913B1 (en) | 2003-03-07 | 2012-06-26 | Rubicon Genomics, Inc. | Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process |
DK2374900T3 (en) | 2003-03-07 | 2016-10-17 | Rubicon Genomics Inc | Polynucleotides for amplification and analysis of the total genomic and total transcription libraries generated by a DNA polymerization |
WO2004092418A2 (en) * | 2003-04-14 | 2004-10-28 | Nugen Technologies, Inc. | Global amplification using a randomly primed composite primer |
EP1711591A4 (en) | 2003-12-29 | 2010-04-28 | Nugen Technologies Inc | Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
WO2005080570A1 (en) | 2004-02-24 | 2005-09-01 | Mitsubishi Rayon Co., Ltd. | Gene relating to estimation of postoperative prognosis for breast cancer |
EP2290106B1 (en) | 2004-03-08 | 2018-01-03 | Rubicon Genomics, Inc. | Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
US7758896B2 (en) * | 2004-04-16 | 2010-07-20 | University Of Massachusetts | Porous calcium phosphate networks for synthetic bone material |
US7713697B2 (en) * | 2004-08-27 | 2010-05-11 | Gen-Probe Incorporated | Methods and kits for amplifying DNA |
EP2071031B1 (en) * | 2004-08-27 | 2013-10-09 | Gen-Probe Incorporated | Single-primer nucleic acid amplification methods |
WO2006033487A1 (en) * | 2004-09-21 | 2006-03-30 | Genomictree Inc. | Method for linear amplification of rna using high-heel primer |
WO2006086668A2 (en) * | 2005-02-09 | 2006-08-17 | Epicentre Technologies | Compositions and methods employing 5'-phosphate-dependent nucleic acid exonucleases |
US20060264783A1 (en) | 2005-05-09 | 2006-11-23 | Holmes Elizabeth A | Systems and methods for monitoring pharmacological parameters |
EP2703499A1 (en) | 2005-06-02 | 2014-03-05 | Fluidigm Corporation | Analysis using microfluidic partitioning devices to generate single cell samples |
WO2007018602A1 (en) | 2005-08-02 | 2007-02-15 | Rubicon Genomics, Inc. | Isolation of cpg islands by thermal segregation and enzymatic selection-amplification method |
DK1924704T3 (en) | 2005-08-02 | 2011-09-05 | Rubicon Genomics Inc | Compositions and Methods for Processing and Multiplying DNA, including Using Multiple Enzymes in a Single Reaction |
US20070048741A1 (en) * | 2005-08-24 | 2007-03-01 | Getts Robert C | Methods and kits for sense RNA synthesis |
CA2621267A1 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
WO2007100986A2 (en) * | 2006-02-24 | 2007-09-07 | Rosetta Inpharmatics Llc | Extraction and diagnostic fluid devices, systems and methods of use |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
CA2652052A1 (en) * | 2006-05-16 | 2007-11-29 | Nugen Technologies, Inc. | Nucleic acid separation and purification method based on reversible charge interactions |
US11001881B2 (en) | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
US7833716B2 (en) | 2006-06-06 | 2010-11-16 | Gen-Probe Incorporated | Tagged oligonucleotides and their use in nucleic acid amplification methods |
CA2656315A1 (en) * | 2006-06-30 | 2008-01-10 | Nugen Technologies, Inc. | Methods for fragmentation and labeling of nucleic acids |
US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
WO2008014485A2 (en) | 2006-07-28 | 2008-01-31 | California Institute Of Technology | Multiplex q-pcr arrays |
US8980561B1 (en) | 2006-08-22 | 2015-03-17 | Los Alamos National Security, Llc. | Nucleic acid detection system and method for detecting influenza |
US20090047673A1 (en) | 2006-08-22 | 2009-02-19 | Cary Robert B | Miniaturized lateral flow device for rapid and sensitive detection of proteins or nucleic acids |
US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
US8183359B2 (en) * | 2007-03-01 | 2012-05-22 | Gen-Probe Incorporated | Kits for amplifying DNA |
AU2008308686B2 (en) | 2007-10-02 | 2015-01-22 | Labrador Diagnostics Llc | Modular point-of-care devices and uses thereof |
CN102124126A (en) * | 2007-10-26 | 2011-07-13 | 生命技术公司 | Cdna synthesis using non-random primers |
EP2247727A4 (en) * | 2008-02-12 | 2011-08-03 | Nugen Technologies Inc | Method for archiving and clonal expansion |
US8034568B2 (en) * | 2008-02-12 | 2011-10-11 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
US20090215050A1 (en) * | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
GB2470672B (en) * | 2008-03-21 | 2012-09-12 | Nugen Technologies Inc | Methods of RNA amplification in the presence of DNA |
WO2009137369A1 (en) * | 2008-05-03 | 2009-11-12 | Tufts Medical Center, Inc. | Neonatal salivary genomics |
WO2009137059A1 (en) | 2008-05-05 | 2009-11-12 | Los Alamos National Security, Llc | Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control |
WO2010126913A1 (en) | 2009-04-27 | 2010-11-04 | Gen-Probe Incorporated | Methods and kits for use in the selective amplification of target sequences |
US9309566B2 (en) | 2010-12-17 | 2016-04-12 | Life Technologies Corporation | Methods, compositions, systems, apparatuses and kits for nucleic acid amplification |
US9309557B2 (en) | 2010-12-17 | 2016-04-12 | Life Technologies Corporation | Nucleic acid amplification |
US9334531B2 (en) | 2010-12-17 | 2016-05-10 | Life Technologies Corporation | Nucleic acid amplification |
CA2773887A1 (en) * | 2009-09-11 | 2011-03-17 | Nugen Technologies, Inc. | Compositions and methods for whole transcriptome analysis |
WO2011055737A1 (en) * | 2009-11-06 | 2011-05-12 | 株式会社ニッポンジーン | Thermostable strand displacement dna polymerase and method for producing the dna polymerase |
CN101935697B (en) * | 2010-04-16 | 2015-11-25 | 中生方政生物技术有限公司 | The method detected for nucleotide sequence and test kit |
EP2652148B1 (en) * | 2010-12-17 | 2016-11-30 | Life Technologies Corporation | Methods, compositions, systems, apparatuses and kits for nucleic acid amplification |
AR085087A1 (en) | 2011-01-21 | 2013-09-11 | Theranos Inc | SYSTEMS AND METHODS TO MAXIMIZE THE USE OF SAMPLES |
US8759036B2 (en) | 2011-03-21 | 2014-06-24 | Affymetrix, Inc. | Methods for synthesizing pools of probes |
PT2699698T (en) | 2011-04-20 | 2017-04-11 | Mesa Biotech Inc | Oscillating amplification reaction for nucleic acids |
US8435738B2 (en) | 2011-09-25 | 2013-05-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US9268915B2 (en) | 2011-09-25 | 2016-02-23 | Theranos, Inc. | Systems and methods for diagnosis or treatment |
US9632102B2 (en) | 2011-09-25 | 2017-04-25 | Theranos, Inc. | Systems and methods for multi-purpose analysis |
US8475739B2 (en) | 2011-09-25 | 2013-07-02 | Theranos, Inc. | Systems and methods for fluid handling |
US20140170735A1 (en) | 2011-09-25 | 2014-06-19 | Elizabeth A. Holmes | Systems and methods for multi-analysis |
US8380541B1 (en) | 2011-09-25 | 2013-02-19 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
US8840838B2 (en) | 2011-09-25 | 2014-09-23 | Theranos, Inc. | Centrifuge configurations |
US9664702B2 (en) | 2011-09-25 | 2017-05-30 | Theranos, Inc. | Fluid handling apparatus and configurations |
CN103946364B (en) | 2011-09-25 | 2018-04-24 | 赛拉诺斯知识产权有限责任公司 | System and method for multiple analysis |
US9250229B2 (en) | 2011-09-25 | 2016-02-02 | Theranos, Inc. | Systems and methods for multi-analysis |
US9810704B2 (en) | 2013-02-18 | 2017-11-07 | Theranos, Inc. | Systems and methods for multi-analysis |
US10012664B2 (en) | 2011-09-25 | 2018-07-03 | Theranos Ip Company, Llc | Systems and methods for fluid and component handling |
EP2769007B1 (en) | 2011-10-19 | 2016-12-07 | Nugen Technologies, Inc. | Compositions and methods for directional nucleic acid amplification and sequencing |
GB201121869D0 (en) * | 2011-11-17 | 2012-02-01 | Clarient Inc | Method of allele-specific amplification |
EP2798089B1 (en) | 2011-12-30 | 2018-05-23 | Bio-rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
WO2013112923A1 (en) | 2012-01-26 | 2013-08-01 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
ES2663234T3 (en) | 2012-02-27 | 2018-04-11 | Cellular Research, Inc | Compositions and kits for molecular counting |
JP6445426B2 (en) | 2012-05-10 | 2018-12-26 | ザ ジェネラル ホスピタル コーポレイション | Method for determining nucleotide sequence |
KR101184566B1 (en) | 2012-05-11 | 2012-09-20 | 케이맥(주) | Method for integrated analysis of real-time pcr and dna chip |
CA2877094A1 (en) | 2012-06-18 | 2013-12-27 | Nugen Technologies, Inc. | Compositions and methods for negative selection of non-desired nucleic acid sequences |
US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
EP2895622A4 (en) | 2012-09-11 | 2016-05-18 | Theranos Inc | Information management systems and methods using a biological signature |
CN102962015B (en) * | 2012-11-20 | 2014-04-23 | 北京大学 | DNA (Deoxyribose Nucleic Acid) or RNA (Ribose Nucleic Acid) synthesizer with fixed nanometer material microballoons serving as base |
CN109813923A (en) | 2013-02-18 | 2019-05-28 | 赛拉诺斯知识产权有限责任公司 | System and method for acquiring and transmitting measurement result |
WO2014138688A1 (en) * | 2013-03-07 | 2014-09-12 | Bio-Rad Laboratories, Inc. | Repetitive reverse transcription partition assay |
US9428747B2 (en) * | 2013-03-15 | 2016-08-30 | Lyle J. Arnold | Methods for amplification of nucleic acids utilizing hairpin loop or duplex primers |
WO2014144092A1 (en) | 2013-03-15 | 2014-09-18 | Nugen Technologies, Inc. | Sequential sequencing |
EP3039158B1 (en) | 2013-08-28 | 2018-11-14 | Cellular Research, Inc. | Massively parallel single cell analysis |
US9907867B2 (en) | 2013-09-26 | 2018-03-06 | General Electric Company | Systems, methods and apparatus for manufacturing radioisotopes |
EP3068883B1 (en) | 2013-11-13 | 2020-04-29 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
EP3495506B1 (en) | 2013-12-11 | 2023-07-12 | AccuraGen Holdings Limited | Methods for detecting rare sequence variants |
US11859246B2 (en) | 2013-12-11 | 2024-01-02 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
US11286519B2 (en) | 2013-12-11 | 2022-03-29 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
WO2015112974A1 (en) | 2014-01-27 | 2015-07-30 | The General Hospital Corporation | Methods of preparing nucleic acids for sequencing |
WO2015131107A1 (en) | 2014-02-28 | 2015-09-03 | Nugen Technologies, Inc. | Reduced representation bisulfite sequencing with diversity adaptors |
SG11201700891SA (en) | 2014-08-06 | 2017-03-30 | Nugen Technologies Inc | Digital measurements from targeted sequencing |
CN107208162B (en) * | 2015-02-26 | 2020-12-29 | 株式会社日立高新技术 | Method for constructing nucleic acid molecule |
WO2016138496A1 (en) | 2015-02-27 | 2016-09-01 | Cellular Research, Inc. | Spatially addressable molecular barcoding |
CN104673786A (en) * | 2015-03-09 | 2015-06-03 | 武汉格蓝丽富科技有限公司 | Method for selective amplification of RNA |
US9708647B2 (en) | 2015-03-23 | 2017-07-18 | Insilixa, Inc. | Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays |
WO2016160844A2 (en) | 2015-03-30 | 2016-10-06 | Cellular Research, Inc. | Methods and compositions for combinatorial barcoding |
WO2016172373A1 (en) | 2015-04-23 | 2016-10-27 | Cellular Research, Inc. | Methods and compositions for whole transcriptome amplification |
US9499861B1 (en) | 2015-09-10 | 2016-11-22 | Insilixa, Inc. | Methods and systems for multiplex quantitative nucleic acid amplification |
ES2745694T3 (en) | 2015-09-11 | 2020-03-03 | Cellular Res Inc | Methods and compositions for nucleic acid library normalization |
CN108368545B (en) | 2015-10-09 | 2022-05-17 | 安可济控股有限公司 | Methods and compositions for enriching amplification products |
WO2017096322A1 (en) | 2015-12-03 | 2017-06-08 | Accuragen Holdings Limited | Methods and compositions for forming ligation products |
WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
US9617587B1 (en) | 2016-04-04 | 2017-04-11 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
US11299777B2 (en) | 2016-04-04 | 2022-04-12 | Nat Diagnostics, Inc. | Isothermal amplification components and processes |
US11427866B2 (en) | 2016-05-16 | 2022-08-30 | Accuragen Holdings Limited | Method of improved sequencing by strand identification |
US10301677B2 (en) | 2016-05-25 | 2019-05-28 | Cellular Research, Inc. | Normalization of nucleic acid libraries |
US10640763B2 (en) | 2016-05-31 | 2020-05-05 | Cellular Research, Inc. | Molecular indexing of internal sequences |
US10202641B2 (en) | 2016-05-31 | 2019-02-12 | Cellular Research, Inc. | Error correction in amplification of samples |
CN107541508A (en) * | 2016-06-24 | 2018-01-05 | 广州康昕瑞基因健康科技有限公司 | Templa-primer nucleic acid molecules, polymerase activity assay method and kit |
SG11201901296TA (en) | 2016-08-15 | 2019-03-28 | Accuragen Holdings Ltd | Compositions and methods for detecting rare sequence variants |
CA3037190A1 (en) | 2016-09-15 | 2018-03-22 | ArcherDX, Inc. | Methods of nucleic acid sample preparation for analysis of cell-free dna |
AU2017328950B2 (en) | 2016-09-15 | 2023-09-14 | Archerdx, Llc | Methods of nucleic acid sample preparation |
KR102363716B1 (en) | 2016-09-26 | 2022-02-18 | 셀룰러 리서치, 인크. | Determination of protein expression using reagents having barcoded oligonucleotide sequences |
CA3038178A1 (en) | 2016-09-30 | 2018-04-05 | The Governing Council Of The University Of Toronto | System for identifying and targeting individual cells within a heterogeneous population for selective extraction of cellular content |
US11319583B2 (en) | 2017-02-01 | 2022-05-03 | Becton, Dickinson And Company | Selective amplification using blocking oligonucleotides |
JP7056012B2 (en) * | 2017-05-19 | 2022-04-19 | トヨタ自動車株式会社 | Random primer set and method for preparing a DNA library using it |
JP2020522262A (en) | 2017-06-05 | 2020-07-30 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Sample index addition for single cells |
CN107287320A (en) * | 2017-07-12 | 2017-10-24 | 曹国君 | The LAMP detections of GAPDH genes are combined and kit with primer |
US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
US11203782B2 (en) | 2018-03-29 | 2021-12-21 | Accuragen Holdings Limited | Compositions and methods comprising asymmetric barcoding |
EP4234717A3 (en) | 2018-05-03 | 2023-11-01 | Becton, Dickinson and Company | High throughput multiomics sample analysis |
CN112243461A (en) | 2018-05-03 | 2021-01-19 | 贝克顿迪金森公司 | Molecular barcoding at opposite transcript ends |
WO2019236726A1 (en) | 2018-06-06 | 2019-12-12 | The Regents Of The University Of California | Methods of producing nucleic acid libraries and compositions and kits for practicing same |
CN112805389A (en) | 2018-10-01 | 2021-05-14 | 贝克顿迪金森公司 | Determination of 5' transcript sequences |
WO2020097315A1 (en) | 2018-11-08 | 2020-05-14 | Cellular Research, Inc. | Whole transcriptome analysis of single cells using random priming |
US11492660B2 (en) | 2018-12-13 | 2022-11-08 | Becton, Dickinson And Company | Selective extension in single cell whole transcriptome analysis |
EP3914728B1 (en) | 2019-01-23 | 2023-04-05 | Becton, Dickinson and Company | Oligonucleotides associated with antibodies |
CN113924041A (en) | 2019-03-14 | 2022-01-11 | 因斯利克萨公司 | Method and system for fluorescence detection based on time gating |
AU2020247700A1 (en) * | 2019-03-25 | 2021-10-14 | The Board Of Trustees Of The Leland Stanford Junior University | Signature for diagnosis of bacterial VS viral infections |
WO2020218831A1 (en) * | 2019-04-22 | 2020-10-29 | 포항공과대학교 산학협력단 | Novel probe set for isothermal one-pot reaction, and uses thereof |
CN110241178B (en) * | 2019-06-25 | 2023-03-31 | 北京博奥晶方生物科技有限公司 | Single-cell transcriptome sequencing high-throughput rapid library preparation method and detection kit |
EP4004231A1 (en) | 2019-07-22 | 2022-06-01 | Becton, Dickinson and Company | Single cell chromatin immunoprecipitation sequencing assay |
US11773436B2 (en) | 2019-11-08 | 2023-10-03 | Becton, Dickinson And Company | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing |
WO2021146207A1 (en) | 2020-01-13 | 2021-07-22 | Becton, Dickinson And Company | Methods and compositions for quantitation of proteins and rna |
CN115605614A (en) | 2020-05-14 | 2023-01-13 | 贝克顿迪金森公司(Us) | Primers for immune repertoire profiling |
US11932901B2 (en) | 2020-07-13 | 2024-03-19 | Becton, Dickinson And Company | Target enrichment using nucleic acid probes for scRNAseq |
EP4247967A1 (en) | 2020-11-20 | 2023-09-27 | Becton, Dickinson and Company | Profiling of highly expressed and lowly expressed proteins |
CN114410778B (en) * | 2021-12-29 | 2024-03-19 | 中南大学湘雅医院 | Application of PF543 in preparation of PD-L1/PD-1 monoclonal antibody tumor immunotherapy medicament |
Family Cites Families (246)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4174384A (en) | 1975-06-30 | 1979-11-13 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US3999345A (en) | 1975-11-10 | 1976-12-28 | Shatterproof Glass Corporation | Spandrel units |
US4261968A (en) | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
BR8108820A (en) | 1980-09-24 | 1982-08-24 | Cetus Corp | DIAGNOSTIC PROCESS AND PROBE |
US4362867A (en) | 1980-12-10 | 1982-12-07 | Research Corporation | Recombinant cDNA construction method and hybrid nucleotides useful in cloning |
US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
EP0084796B1 (en) | 1982-01-22 | 1990-05-02 | Cetus Corporation | Hla typing method and cdna probes used therein |
US4786600A (en) | 1984-05-25 | 1988-11-22 | The Trustees Of Columbia University In The City Of New York | Autocatalytic replication of recombinant RNA |
US4683194A (en) | 1984-05-29 | 1987-07-28 | Cetus Corporation | Method for detection of polymorphic restriction sites and nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5011769A (en) | 1985-12-05 | 1991-04-30 | Meiogenics U.S. Limited Partnership | Methods for detecting nucleic acid sequences |
US4876187A (en) | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
US4996143A (en) | 1985-12-23 | 1991-02-26 | Syngene, Inc. | Fluorescent stokes shift probes for polynucleotide hybridization |
US5721098A (en) | 1986-01-16 | 1998-02-24 | The Regents Of The University Of California | Comparative genomic hybridization |
CA1284931C (en) | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5849478A (en) | 1986-08-14 | 1998-12-15 | Cashman; Daniel P. | Blocked-polymerase polynucleotide immunoassay method and kit |
CA1338457C (en) | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
DE3634356A1 (en) | 1986-10-08 | 1988-04-21 | Epis Sa | MEDICINE CONTAINING ALPHA-HALOGENED DICARBONIC ACIDS |
US6270961B1 (en) | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Method and kits for the amplification and detection of nucleic acid sequences |
US6090591A (en) | 1987-07-31 | 2000-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
WO1989001050A1 (en) | 1987-07-31 | 1989-02-09 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
US6004745A (en) | 1987-09-21 | 1999-12-21 | Gen-Probe Incorporated | Hybridization protection assay |
US5403711A (en) | 1987-11-30 | 1995-04-04 | University Of Iowa Research Foundation | Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
AU622426B2 (en) | 1987-12-11 | 1992-04-09 | Abbott Laboratories | Assay using template-dependent nucleic acid probe reorganization |
WO1989006700A1 (en) | 1988-01-21 | 1989-07-27 | Genentech, Inc. | Amplification and detection of nucleic acid sequences |
JP2650159B2 (en) | 1988-02-24 | 1997-09-03 | アクゾ・ノベル・エヌ・ベー | Nucleic acid amplification method |
CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
EP0365627B1 (en) | 1988-03-24 | 1993-12-22 | University Of Iowa Research Foundation | Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved |
US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
ATE138106T1 (en) | 1988-07-20 | 1996-06-15 | David Segev | METHOD FOR AMPLIFICATION AND DETECTION OF NUCLEIC ACID SEQUENCES |
US5185243A (en) | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
US5508178A (en) | 1989-01-19 | 1996-04-16 | Rose; Samuel | Nucleic acid amplification using single primer |
US5708154A (en) | 1989-02-24 | 1998-01-13 | City Of Hope | RNA-DNA hybrid molecules of nucleic acid |
US5106727A (en) | 1989-04-27 | 1992-04-21 | Life Technologies, Inc. | Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers |
US5043272A (en) | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
AU650622B2 (en) | 1989-07-11 | 1994-06-30 | Gen-Probe Incorporated | Nucleic acid sequence amplification methods utilizing a transcription complex |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
US5766849A (en) | 1989-07-11 | 1998-06-16 | Gen-Probe Incorporated | Methods of amplifying nucleic acids using promoter-containing primer sequence |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5427930A (en) | 1990-01-26 | 1995-06-27 | Abbott Laboratories | Amplification of target nucleic acids using gap filling ligase chain reaction |
US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
CA2037349C (en) | 1990-03-26 | 2008-06-17 | James G. Wetmur | Branch migration of nucleotides |
US5427911A (en) | 1990-05-01 | 1995-06-27 | Yale University | Coupled amplification and sequencing of DNA |
HU218095B (en) | 1990-05-01 | 2000-05-28 | Amgen Inc. | Process for reducing transitional contaminations in amplification processes |
US5194370A (en) | 1990-05-16 | 1993-03-16 | Life Technologies, Inc. | Promoter ligation activated transcription amplification of nucleic acid sequences |
US5693502A (en) | 1990-06-11 | 1997-12-02 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand inhibitors to DNA polymerases |
US5595891A (en) | 1990-07-19 | 1997-01-21 | Behringwerke Ag | Method for producing a polynucleotide for use in single primer amplification |
US5527872A (en) | 1990-09-14 | 1996-06-18 | At&T Global Information Solutions Company | Electronic device with a spin-on glass dielectric layer |
US6083689A (en) | 1990-10-16 | 2000-07-04 | Bayer Corporation | Sensitive immunoassays utilizing antibody conjugates with replicable DNA templates |
US5846710A (en) | 1990-11-02 | 1998-12-08 | St. Louis University | Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension |
US5175243A (en) | 1990-11-14 | 1992-12-29 | Phillips Petroleum Company | Process for preparing arylene sulfide polymers with halo benzene containing deactivating group |
US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
KR930009227B1 (en) | 1991-01-31 | 1993-09-24 | 삼성전자 주식회사 | Brake driving apparatus of tape recorder |
AU8997991A (en) | 1991-01-31 | 1992-08-06 | Becton Dickinson & Company | Exonuclease mediated strand displacement amplification |
US5888819A (en) | 1991-03-05 | 1999-03-30 | Molecular Tool, Inc. | Method for determining nucleotide identity through primer extension |
US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
US5090591A (en) | 1991-03-18 | 1992-02-25 | Longford Equipment International Limited | Article dispenser for use with continuous strip of articles |
WO1992018521A1 (en) | 1991-04-10 | 1992-10-29 | Life Technologies, Inc. | Method for amplifying and altering an rna sequence |
US5340716A (en) | 1991-06-20 | 1994-08-23 | Snytex (U.S.A.) Inc. | Assay method utilizing photoactivated chemiluminescent label |
US5169766A (en) | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
US5328985A (en) | 1991-07-12 | 1994-07-12 | The Regents Of The University Of California | Recombinant streptavidin-protein chimeras useful for conjugation of molecules in the immune system |
US5665539A (en) | 1991-07-12 | 1997-09-09 | The Regents Of The University Of California | Immuno-polymerase chain reaction system for antigen detection |
JP3509859B2 (en) | 1991-11-07 | 2004-03-22 | ナノトロニクス,インコーポレイテッド | Hybridization of chromophore and fluorophore conjugated polynucleotides to create donor-donor energy transfer systems |
US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
DE69326685T2 (en) | 1992-02-04 | 2000-06-08 | Nen Life Science Prod Inc | AMPLIFICATION OF TEST REPORTERS BY NUCLEIC ACID REPLICATION |
US5262311A (en) | 1992-03-11 | 1993-11-16 | Dana-Farber Cancer Institute, Inc. | Methods to clone polyA mRNA |
JP2843675B2 (en) | 1992-03-11 | 1999-01-06 | ダナ−ファーバー・キャンサー・インスチチュート・インコーポレーテッド | Identification, isolation and cloning of messenger RNA |
CA2135073C (en) | 1992-05-06 | 2002-11-19 | Daniel L. Kacian | Nucleic acid sequence amplification method, composition and kit |
AU4387193A (en) | 1992-05-29 | 1993-12-30 | Abbott Laboratories | Ligase chain reaction starting with rna sequences |
US5710028A (en) | 1992-07-02 | 1998-01-20 | Eyal; Nurit | Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor |
US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
ES2113547T3 (en) | 1992-07-31 | 1998-05-01 | Behringwerke Ag | PHOTOACTIVABLE CHEMIOLUMINISCENT MATRICES. |
ATE152180T1 (en) | 1992-07-31 | 1997-05-15 | Behringwerke Ag | METHOD FOR INTRODUCING DEFINED SEQUENCES AT THE 3' END OF POLYNUCLEOTIDES |
ZA936016B (en) | 1992-08-24 | 1994-03-10 | Akzo Nv | Method for nucleic acid amplification |
RU2048522C1 (en) | 1992-10-14 | 1995-11-20 | Институт белка РАН | Method of nucleic acid copying, method of their expression and a medium for their realization |
US5445935A (en) | 1992-11-23 | 1995-08-29 | Royer; Catherine A. | Quantitative detection of macromolecules with fluorescent oligonucleotides |
US5571669A (en) | 1993-01-14 | 1996-11-05 | The University Of Pennsylvania | Transcription and nucleic acid sequence determination with short primer DNA/RNA molecules and RNA polymerase |
US5985548A (en) | 1993-02-04 | 1999-11-16 | E. I. Du Pont De Nemours And Company | Amplification of assay reporters by nucleic acid replication |
US5591575A (en) | 1993-04-07 | 1997-01-07 | Amersham International Plc | Subtraction hybridization employing aziridinylbenoquinone cross-linking agents |
US5714320A (en) | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
US6096715A (en) | 1993-05-07 | 2000-08-01 | City Of Hope | Chimeric DNA-RNA catalytic sequences |
JPH06327500A (en) * | 1993-05-20 | 1994-11-29 | Toyobo Co Ltd | Method for multiplying nucleic acid sequence and method for detecting same |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
JPH0723799A (en) | 1993-07-13 | 1995-01-27 | Hitachi Ltd | Method for detecting polynucleotide |
US6027923A (en) | 1993-07-23 | 2000-02-22 | Bio-Rad Laboratories, Inc. | Linked linear amplification of nucleic acids |
US5731171A (en) | 1993-07-23 | 1998-03-24 | Arch Development Corp. | Sequence independent amplification of DNA |
FR2708288B1 (en) | 1993-07-26 | 1995-09-01 | Bio Merieux | Method for amplification of nucleic acids by transcription using displacement, reagents and necessary for the implementation of this method. |
AU7487294A (en) | 1993-08-18 | 1995-03-14 | Id Biomedical Corporation | Compositions and methods for detecting target nucleic acid sequences utilizing flanking sequence enzyme molecules |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
DE69426731T2 (en) | 1993-11-17 | 2001-06-28 | Amersham Pharm Biotech Uk Ltd | METHOD FOR MASS SPECTROSCOPIC SEQUENCE ANALYSIS OF A NUCLEIC ACID BY PRIMER EXTENSION |
AU8102694A (en) | 1993-11-17 | 1995-06-06 | Id Biomedical Corporation | Cycling probe cleavage detection of nucleic acid sequences |
CA2140081C (en) | 1994-01-13 | 2008-04-01 | Dean L. Engelhardt | Process, construct and conjugate for producing multiple nucleic acid copies |
US5654419A (en) | 1994-02-01 | 1997-08-05 | The Regents Of The University Of California | Fluorescent labels and their use in separations |
EP0754240B1 (en) | 1994-02-07 | 2003-08-20 | Beckman Coulter, Inc. | Ligase/polymerase-mediated genetic bit analysis of single nucleotide polymorphisms and its use in genetic analysis |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
US5705332A (en) | 1994-04-25 | 1998-01-06 | University Of Hawaii | Detection and identification of Salmonella and Shigella |
US6060288A (en) | 1994-08-03 | 2000-05-09 | Mosaic Technologies | Method for performing amplification of nucleic acid on supports |
US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
US5491063A (en) | 1994-09-01 | 1996-02-13 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
FR2724934B1 (en) | 1994-09-26 | 1997-01-24 | Bio Merieux | CHIMERIC OLIGONUCLEOTIDE AND ITS USE IN OBTAINING NUCLEIC ACID TRANSCRIPTS |
US6280935B1 (en) | 1994-10-13 | 2001-08-28 | Lynx Therapeutics, Inc. | Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US6309843B1 (en) | 1994-10-25 | 2001-10-30 | The Curators Of The University Of Missouri | Glycoprotein for use in determining endometrial receptivity |
US5665545A (en) * | 1994-11-28 | 1997-09-09 | Akzo Nobel N.V. | Terminal repeat amplification method |
US5556771A (en) | 1995-02-10 | 1996-09-17 | Gen-Probe Incorporated | Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification |
US5830655A (en) | 1995-05-22 | 1998-11-03 | Sri International | Oligonucleotide sizing using cleavable primers |
US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
US5882867A (en) | 1995-06-07 | 1999-03-16 | Dade Behring Marburg Gmbh | Detection of nucleic acids by formation of template-dependent product |
US5932450A (en) | 1995-06-07 | 1999-08-03 | Gen-Probe Incorporated | Enzymatic synthesis of oligonucleotides using digestible templates |
US5916777A (en) | 1995-06-07 | 1999-06-29 | Gen-Probe Incorporated | Enzymatic synthesis of oligonucleotides using 3'-ribonucleotide primers |
US5763178A (en) | 1995-06-07 | 1998-06-09 | Trevigen, Inc. | Oscillating signal amplifier for nucleic acid detection |
JPH0920263A (en) | 1995-07-06 | 1997-01-21 | Jidosha Kiki Co Ltd | Motor-driven pump type power steering device |
US5989813A (en) | 1995-07-13 | 1999-11-23 | Molecular Innovations, Inc. | Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles |
WO1997004123A1 (en) | 1995-07-19 | 1997-02-06 | Gel Tech Group Inc. | Collagen compound production in plants |
FR2737223B1 (en) | 1995-07-24 | 1997-09-12 | Bio Merieux | METHOD OF AMPLIFYING NUCLEIC ACID SEQUENCES BY MOVEMENT USING CHIMERIC PRIMERS |
US5652356A (en) | 1995-08-17 | 1997-07-29 | Hybridon, Inc. | Inverted chimeric and hybrid oligonucleotides |
US6068829A (en) | 1995-09-11 | 2000-05-30 | The Burnham Institute | Method of identifying molecules that home to a selected organ in vivo |
US5916779A (en) | 1995-09-21 | 1999-06-29 | Becton, Dickinson And Company | Strand displacement amplification of RNA targets |
US5747255A (en) | 1995-09-29 | 1998-05-05 | Lynx Therapeutics, Inc. | Polynucleotide detection by isothermal amplification using cleavable oligonucleotides |
US5871697A (en) | 1995-10-24 | 1999-02-16 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
DE69612013T2 (en) | 1995-11-21 | 2001-08-02 | Univ Yale New Haven | UNIMOLECULAR SEGMENT AMPLIFICATION AND DETERMINATION |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
JP4073038B2 (en) | 1995-12-15 | 2008-04-09 | ジーイー・ヘルスケア・バイオサイエンス・コーポレイション | Thermostable DNA polymerase from Thermoanaerobacter thermohydrosulfurica and its mutant enzyme from which exonuclease activity has been removed |
US5962271A (en) | 1996-01-03 | 1999-10-05 | Cloutech Laboratories, Inc. | Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
US5932449A (en) | 1996-02-01 | 1999-08-03 | The United States Of America As Represented By The Secretary Of The Army | Detection of botulinum toxin |
GB9604267D0 (en) | 1996-02-29 | 1996-05-01 | Royal Infirmary Of Edinburgh N | Mutation assay |
US5712127A (en) | 1996-04-29 | 1998-01-27 | Genescape Inc. | Subtractive amplification |
EP0912761A4 (en) | 1996-05-29 | 2004-06-09 | Cornell Res Foundation Inc | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
US5958546A (en) | 1996-07-08 | 1999-09-28 | Mardix; Bar-Cochva | Custom insoles |
US6218105B1 (en) | 1996-07-19 | 2001-04-17 | Kathleen S. Hall | High throughput papilloma virus in vitro infectivity assay |
US5858665A (en) | 1996-07-25 | 1999-01-12 | Navix, Inc. | Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
US5853990A (en) | 1996-07-26 | 1998-12-29 | Edward E. Winger | Real time homogeneous nucleotide assay |
EP0923557A4 (en) | 1996-08-09 | 1999-12-08 | Merck & Co Inc | Stereoselective deoxygenation reaction |
EP0942917B1 (en) | 1996-08-14 | 2015-02-25 | Life Technologies Corporation | Method for nucleic acid amplification and sequencing using stable compositions |
US6255060B1 (en) | 1996-11-21 | 2001-07-03 | Trustees Of The University Of Pennsylvania | Method of detecting protein by immuno RNA |
US5958703A (en) | 1996-12-03 | 1999-09-28 | Glaxo Group Limited | Use of modified tethers in screening compound libraries |
DE19653439A1 (en) | 1996-12-20 | 1998-07-02 | Svante Dr Paeaebo | Methods for the direct, exponential amplification and sequencing of DNA molecules and their application |
US6482590B1 (en) | 1996-12-20 | 2002-11-19 | Aventis Behring Gmbh | Method for polynucleotide amplification |
EP3034626A1 (en) | 1997-04-01 | 2016-06-22 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
JP3666604B2 (en) | 1997-04-16 | 2005-06-29 | アプレラ コーポレーション | Nucleic acid archiving |
US6566101B1 (en) | 1997-06-16 | 2003-05-20 | Anthony P. Shuber | Primer extension methods for detecting nucleic acids |
CA2294053A1 (en) | 1997-06-25 | 1998-12-30 | Orchid Biocomputer, Inc. | Methods for the detection of multiple single nucleotide polymorphisms in a single reaction |
US6136533A (en) | 1997-07-03 | 2000-10-24 | Id Biomedical | Additives for use in cycling probe reactions |
US6140086A (en) | 1997-08-15 | 2000-10-31 | Fox; Donna K. | Methods and compositions for cloning nucleic acid molecules |
US6124120A (en) | 1997-10-08 | 2000-09-26 | Yale University | Multiple displacement amplification |
US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
AU753505B2 (en) | 1997-10-30 | 2002-10-17 | Cold Spring Harbor Laboratory | Probe arrays and methods of using probe arrays for distinguishing DNA |
US5932451A (en) | 1997-11-19 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Method for unbiased mRNA amplification |
US6345481B1 (en) | 1997-11-25 | 2002-02-12 | Premark Rwp Holdings, Inc. | Article with interlocking edges and covering product prepared therefrom |
WO1999029901A1 (en) | 1997-12-11 | 1999-06-17 | The General Hospital Corporation | Broad range pcr amplification techniques |
JP4317953B2 (en) | 1998-01-22 | 2009-08-19 | 独立行政法人理化学研究所 | DNA sequence determination method |
US20010000077A1 (en) | 1998-02-03 | 2001-03-29 | Engelhardt Dean L. | Novel process, construct and conjugate for producing multiple nucleic acid copies |
AU2520799A (en) | 1998-02-05 | 1999-08-23 | Bavarian Nordic Research Institute A/S | Quantification by inhibition of amplification |
US6365346B1 (en) | 1998-02-18 | 2002-04-02 | Dade Behring Inc. | Quantitative determination of nucleic acid amplification products |
US6087103A (en) | 1998-03-04 | 2000-07-11 | Lifespan Biosciences, Inc. | Tagged ligand arrays for identifying target-ligand interactions |
DE19813317A1 (en) | 1998-03-26 | 1999-09-30 | Roche Diagnostics Gmbh | Nucleic acid amplification involving primer extension preamplification, especially for whole genome amplification |
WO1999058724A1 (en) | 1998-05-08 | 1999-11-18 | Life Technologies, Inc. | A method for synthesizing a nucleic acid molecule using a ribonuclease |
US6297170B1 (en) * | 1998-06-23 | 2001-10-02 | Vlsi Technology, Inc. | Sacrificial multilayer anti-reflective coating for mos gate formation |
US6743605B1 (en) | 1998-06-24 | 2004-06-01 | Enzo Life Sciences, Inc. | Linear amplification of specific nucleic acid sequences |
US6316229B1 (en) | 1998-07-20 | 2001-11-13 | Yale University | Single molecule analysis target-mediated ligation of bipartite primers |
GB9817055D0 (en) | 1998-08-05 | 1998-09-30 | Medical Res Council | Reverse transcription and amplification processes and primers therefore |
CA2245039A1 (en) | 1998-08-13 | 2000-02-13 | Vito Scalia | Primer-specific and mispair extension assay for identifying gene variation |
EP2287338B1 (en) | 1998-11-09 | 2012-09-05 | Eiken Kagaku Kabushiki Kaisha | Process for synthesizing nucleic acid |
US20030049657A1 (en) | 1998-11-13 | 2003-03-13 | Cherry Joshua L. | Use of primers containing non-replicatable residues for improved cycle-sequencing of nucleic acids |
US6927024B2 (en) | 1998-11-30 | 2005-08-09 | Genentech, Inc. | PCR assay |
AU774306B2 (en) | 1999-01-05 | 2004-06-24 | Trustees Of Boston University | Improved nucleic acid cloning |
US6358712B1 (en) | 1999-01-05 | 2002-03-19 | Trustee Of Boston University | Ordered gene assembly |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US7074556B2 (en) | 1999-03-02 | 2006-07-11 | Invitrogen Corporation | cDNA synthesis improvements |
US6951722B2 (en) | 1999-03-19 | 2005-10-04 | Takara Bio Inc. | Method for amplifying nucleic acid sequence |
WO2000056925A2 (en) | 1999-03-19 | 2000-09-28 | Aclara Biosciences, Inc. | Methods for single nucleotide polymorphism detection |
ATE362532T1 (en) * | 1999-03-19 | 2007-06-15 | Takara Bio Inc | METHOD FOR AMPLIFYING A NUCLEIC ACID SEQUENCE USING A CHIMERIC PRIMER |
US6355431B1 (en) | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
WO2000070095A2 (en) | 1999-05-17 | 2000-11-23 | Dade Behring Inc. | Homogeneous isothermal amplification and detection of nucleic acids using a template switch oligonucleotide |
US6132997A (en) | 1999-05-28 | 2000-10-17 | Agilent Technologies | Method for linear mRNA amplification |
CA2384838C (en) | 1999-09-13 | 2006-07-18 | Nugen Technologies, Inc. | Methods and compositions for linear isothermal amplification of polynucleotide sequences |
US6692918B2 (en) | 1999-09-13 | 2004-02-17 | Nugen Technologies, Inc. | Methods and compositions for linear isothermal amplification of polynucleotide sequences |
US6107061A (en) | 1999-09-18 | 2000-08-22 | The Perkin-Elmer Corporation | Modified primer extension reactions for polynucleotide sequence detection |
US6617442B1 (en) | 1999-09-30 | 2003-09-09 | Isis Pharmaceuticals, Inc. | Human Rnase H1 and oligonucleotide compositions thereof |
US6300073B1 (en) | 1999-10-01 | 2001-10-09 | Clontech Laboratories, Inc. | One step RT-PCR methods, enzyme mixes and kits for use in practicing the same |
US6271002B1 (en) | 1999-10-04 | 2001-08-07 | Rosetta Inpharmatics, Inc. | RNA amplification method |
US6794138B1 (en) | 1999-12-16 | 2004-09-21 | Affymetrix, Inc. | Methods of small sample amplification |
US7205129B1 (en) | 2000-02-28 | 2007-04-17 | Qiagen Gmbh | Method for reducing artifacts in nucleic acid amplification |
US6376191B1 (en) | 2000-03-22 | 2002-04-23 | Mergen, Ltd. | Microarray-based analysis of polynucleotide sequence variations |
WO2001073134A2 (en) | 2000-03-28 | 2001-10-04 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services, The National Institutes Of Health | Gene profiling arrays |
US7846733B2 (en) | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
WO2002000938A2 (en) * | 2000-06-26 | 2002-01-03 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
US6596490B2 (en) | 2000-07-14 | 2003-07-22 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
US6379932B1 (en) | 2000-07-17 | 2002-04-30 | Incyte Genomics, Inc. | Single primer PCR amplification of RNA |
JP4128074B2 (en) | 2000-08-23 | 2008-07-30 | タカラバイオ株式会社 | Nucleic acid amplification method |
DE60124363T2 (en) | 2000-08-25 | 2007-09-06 | Riken, Wako | Method for the production of standardized and / or subtracted cDNA |
JP4340779B2 (en) | 2000-10-05 | 2009-10-07 | 独立行政法人理化学研究所 | Oligonucleotide linker containing variable overhanging site and method for preparing polynucleotide library using said linker |
US6815164B2 (en) | 2000-10-06 | 2004-11-09 | Nugen Technologies, Inc. | Methods and probes for detection and/or quantification of nucleic acid sequences |
US6673549B1 (en) | 2000-10-12 | 2004-01-06 | Incyte Corporation | Genes expressed in C3A liver cell cultures treated with steroids |
CA2427319A1 (en) | 2000-10-30 | 2002-12-27 | Gene Logic, Inc. | Partially double-stranded nucleic acids, methods of making, and use thereof |
AR031640A1 (en) | 2000-12-08 | 2003-09-24 | Applied Research Systems | ISOTHERMAL AMPLIFICATION OF NUCLEIC ACIDS IN A SOLID SUPPORT |
WO2002048402A2 (en) | 2000-12-13 | 2002-06-20 | Nugen Technologies, Inc. | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
GB0101397D0 (en) | 2001-01-19 | 2001-03-07 | Amersham Pharm Biotech Uk Ltd | Suppression of non-specific nucleic acid amplication |
ZA200210369B (en) | 2001-03-09 | 2004-07-08 | Nugen Technologies Inc | Methods and compositions for amplification or RNA sequences. |
US7094536B2 (en) | 2001-03-09 | 2006-08-22 | Nugen Technologies, Inc. | Methods and compositions for amplification of RNA sequences |
US20040161741A1 (en) | 2001-06-30 | 2004-08-19 | Elazar Rabani | Novel compositions and processes for analyte detection, quantification and amplification |
KR100718220B1 (en) | 2001-07-09 | 2007-05-15 | 아사히 가세이 가부시키가이샤 | Method of Purifying Nucleic Acid Using Nonwoven Fabric and Detection Method |
EP1281757A1 (en) | 2001-07-31 | 2003-02-05 | Direvo Biotech AG | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
GB0118758D0 (en) | 2001-08-01 | 2001-09-26 | Sybesma Wilbert F H | Chimeric primed based real time rt-pcr for qualification of rna or dna templates in a crude sample |
AU2002325538B2 (en) | 2001-08-20 | 2007-03-22 | Takara Bio Inc. | Nucleic acid amplification methods |
US6617137B2 (en) | 2001-10-15 | 2003-09-09 | Molecular Staging Inc. | Method of amplifying whole genomes without subjecting the genome to denaturing conditions |
DE60232013D1 (en) | 2001-11-20 | 2009-05-28 | Exact Sciences Corp | AUTOMATIC SAMPLE PREPARATION METHOD AND DEVICES |
US7176025B2 (en) * | 2002-03-11 | 2007-02-13 | Nugen Technologies, Inc. | Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination |
AU2003220249A1 (en) | 2002-03-15 | 2003-09-29 | Arcturus Bioscience, Inc. | Improved nucleic acid amplification |
US20040023271A1 (en) * | 2002-03-29 | 2004-02-05 | Nurith Kurn | Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
US20040005614A1 (en) | 2002-05-17 | 2004-01-08 | Nurith Kurn | Methods for fragmentation, labeling and immobilization of nucleic acids |
US7205128B2 (en) | 2002-08-16 | 2007-04-17 | Agilent Technologies, Inc. | Method for synthesis of the second strand of cDNA |
AU2004254552B2 (en) | 2003-01-29 | 2008-04-24 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US20060183132A1 (en) | 2005-02-14 | 2006-08-17 | Perlegen Sciences, Inc. | Selection probe amplification |
WO2004092330A2 (en) | 2003-04-11 | 2004-10-28 | Applera Corporation | Method of generating long nucleic acid molecules of defined sequence |
WO2004092418A2 (en) | 2003-04-14 | 2004-10-28 | Nugen Technologies, Inc. | Global amplification using a randomly primed composite primer |
GB0318110D0 (en) | 2003-08-01 | 2003-09-03 | Isaeo Ltd | Methods and kits for detecting an enzyme capable of modifying a nucleic acid |
EP1711591A4 (en) | 2003-12-29 | 2010-04-28 | Nugen Technologies Inc | Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
US7622281B2 (en) | 2004-05-20 | 2009-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for clonal amplification of nucleic acid |
WO2006087574A2 (en) | 2005-02-19 | 2006-08-24 | Geneform Technologies Limited | Isothermal nucleic acid amplification |
WO2006099579A2 (en) | 2005-03-16 | 2006-09-21 | Applera Corporation | Compositions and methods for clonal amplification and analysis of polynucleotides |
SG162795A1 (en) | 2005-06-15 | 2010-07-29 | Callida Genomics Inc | Single molecule arrays for genetic and chemical analysis |
JP2009506788A (en) | 2005-09-06 | 2009-02-19 | ジェン−プローブ・インコーポレーテッド | Methods, compositions and kits for isothermal amplification of nucleic acids |
CA2621267A1 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
WO2007041201A2 (en) | 2005-10-03 | 2007-04-12 | Applera Corporation | Compositions, methods, and kits for amplifying nucleic acids |
CA2652052A1 (en) | 2006-05-16 | 2007-11-29 | Nugen Technologies, Inc. | Nucleic acid separation and purification method based on reversible charge interactions |
US7833716B2 (en) | 2006-06-06 | 2010-11-16 | Gen-Probe Incorporated | Tagged oligonucleotides and their use in nucleic acid amplification methods |
CA2656315A1 (en) | 2006-06-30 | 2008-01-10 | Nugen Technologies, Inc. | Methods for fragmentation and labeling of nucleic acids |
US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
US8034568B2 (en) | 2008-02-12 | 2011-10-11 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
GB2470672B (en) | 2008-03-21 | 2012-09-12 | Nugen Technologies Inc | Methods of RNA amplification in the presence of DNA |
US20110224105A1 (en) | 2009-08-12 | 2011-09-15 | Nugen Technologies, Inc. | Methods, compositions, and kits for generating nucleic acid products substantially free of template nucleic acid |
CA2773887A1 (en) | 2009-09-11 | 2011-03-17 | Nugen Technologies, Inc. | Compositions and methods for whole transcriptome analysis |
WO2011053987A1 (en) | 2009-11-02 | 2011-05-05 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence selection and amplification |
WO2012103154A1 (en) | 2011-01-24 | 2012-08-02 | Nugen Technologies, Inc. | Stem-loop composite rna-dna adaptor-primers: compositions and methods for library generation, amplification and other downstream manipulations |
EP2769007B1 (en) | 2011-10-19 | 2016-12-07 | Nugen Technologies, Inc. | Compositions and methods for directional nucleic acid amplification and sequencing |
WO2013112923A1 (en) | 2012-01-26 | 2013-08-01 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
-
2002
- 2002-03-11 ZA ZA200210369A patent/ZA200210369B/en unknown
- 2002-03-11 IL IL15350402A patent/IL153504A0/en unknown
- 2002-03-11 JP JP2002571828A patent/JP4542312B2/en not_active Expired - Fee Related
- 2002-03-11 AT AT02721342T patent/ATE361996T1/en not_active IP Right Cessation
- 2002-03-11 DE DE60220025T patent/DE60220025T2/en not_active Expired - Lifetime
- 2002-03-11 CN CNB028028279A patent/CN1289690C/en not_active Expired - Fee Related
- 2002-03-11 AU AU2002252279A patent/AU2002252279B2/en not_active Ceased
- 2002-03-11 EP EP02721342A patent/EP1366197B1/en not_active Expired - Lifetime
- 2002-03-11 CA CA2416963A patent/CA2416963C/en not_active Expired - Fee Related
- 2002-03-11 BR BR0205268-7A patent/BR0205268A/en not_active IP Right Cessation
- 2002-03-11 NZ NZ523167A patent/NZ523167A/en not_active IP Right Cessation
- 2002-03-11 KR KR10-2003-7000702A patent/KR20030082535A/en not_active Application Discontinuation
- 2002-03-11 MX MXPA02012739A patent/MXPA02012739A/en active IP Right Grant
- 2002-03-11 WO PCT/US2002/007306 patent/WO2002072772A2/en active IP Right Grant
- 2002-03-11 US US10/100,321 patent/US6946251B2/en not_active Expired - Lifetime
-
2003
- 2003-02-04 NO NO20030557A patent/NO20030557D0/en not_active Application Discontinuation
- 2003-10-14 JP JP2003354377A patent/JP2004267201A/en not_active Withdrawn
-
2004
- 2004-03-16 HK HK04101908A patent/HK1059097A1/en not_active IP Right Cessation
- 2004-08-05 US US10/913,246 patent/US20050003441A1/en not_active Abandoned
- 2004-09-03 US US10/934,890 patent/US7354717B2/en not_active Expired - Lifetime
-
2007
- 2007-10-03 JP JP2007260418A patent/JP2008067709A/en active Pending
-
2008
- 2008-01-25 US US12/020,434 patent/US7771946B2/en not_active Expired - Fee Related
-
2009
- 2009-11-10 US US12/615,958 patent/US8071311B2/en not_active Expired - Fee Related
-
2011
- 2011-10-27 US US13/282,732 patent/US8492095B2/en not_active Expired - Fee Related
-
2013
- 2013-06-19 US US13/922,146 patent/US9181582B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2416963A1 (en) | Methods and compositions for amplification of rna sequences | |
US9175325B2 (en) | Global amplification using a randomly primed composite primer | |
EP1390537B1 (en) | Methods and compositions for amplification of rna sequences | |
JP2004535162A5 (en) | ||
JP2006523465A5 (en) | ||
AU2002252279A1 (en) | Methods and compositions for amplification of RNA sequences | |
CA2474864A1 (en) | Methods and means for amplifying nucleic acid | |
AU2005203617A1 (en) | Methods and compositions for amplification of RNA sequences | |
AU2002303118A1 (en) | Methods and compositions for amplification of RNA sequences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20180312 |